Home › Funds › Avalon Trust Co › PPH

Avalon Trust Co position in PPH

VANECK PHARMACEUTICAL ETF

Avalon Trust Co reported holding 254,155 shares of PPH (VANECK PHARMACEUTICAL ETF) in its Q3 2026 13F filing — a position valued at US$27.8M, representing 1.74% of its reported portfolio and ranking #13 among its reported holdings. Avalon Trust Co has disclosed PPH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)254.16K sh
Reported value held$27.82M
Portfolio Weight1.74%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Avalon Trust Co's PPH position evolved

Avalon Trust Co first disclosed a stake in PPH in Q3 2023 at 287,575 shares (US$23.0M). The position peaked in Q2 2026 at 263,830 shares, worth US$28.8M. Across 13 filings, Avalon Trust Co increased the stake 0 time(s), trimmed it 7 time(s) and left it unchanged 5 time(s). The most recent filing (Q3 2026) shows 254,155 shares valued at US$27.8M — a reduction of -9,675 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 287.57K $22.97M New
Q4 2023 285.38K $23.22M Reduce
Q1 2024 284.88K $25.84M Hold
Q2 2024 284.98K $26.07M Hold
Q3 2024 282.80K $26.87M Reduce
Q4 2024 282.79K $24.40M Hold
Q1 2025 283.69K $25.85M Hold
Q2 2025 280.48K $24.67M Reduce
Q3 2025 275.40K $24.89M Reduce
Q4 2025 267.85K $27.63M Reduce
Q1 2026 267.70K $27.81M Hold
Q2 2026 263.83K $28.85M Reduce
Q3 2026 254.16K $27.82M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PPH and 13F data

PPH (VANECK PHARMACEUTICAL ETF) is a company whose sector is not yet classified in our data. 20 other funds we track also report a position in PPH — the largest reported positions include J.Safra Asset Management Corp (US$35.9M), ADAMSBROWN WEALTH CONSULTANTS LLC (US$11.1M), Rye Brook Capital LLC (US$7.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PPH

All PPH fund holders →

FAQ

How long has Avalon Trust Co held PPH?

Avalon Trust Co has disclosed PPH holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Avalon Trust Co's current position in PPH?

As of Q3 2026, Avalon Trust Co holds 254.16K shares of PPH (VANECK PHARMACEUTICAL ETF), valued at $27.82M, representing 1.74% of its reported portfolio and ranking #13.

Has Avalon Trust Co been buying or selling PPH?

In the latest 13F filing (Q3 2026), Avalon Trust Co reduced its position in PPH. The position peaked in Q2 2026 at 263.83K shares.

Which other funds hold PPH?

Other major institutional holders of PPH include J.Safra Asset Management Corp, ADAMSBROWN WEALTH CONSULTANTS LLC, Rye Brook Capital LLC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.